(2023)
Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma.
EUROPEAN UROLOGY OPEN SCIENCE.
58,
(2023)
Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial.
EUROPEAN UROLOGY.
84,
1
(2023)
Management of Fibroblast Growth Factor Inhibitor Treatment–emergent Adverse Events of Interest in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
EUROPEAN UROLOGY OPEN SCIENCE.
50,
(2023)
Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy.
CANCER RESEARCH AND TREATMENT.
55,
2
(2022)
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure.
EUROPEAN JOURNAL OF CANCER.
174,
(2022)
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
LANCET ONCOLOGY.
23,
9
(2022)
Clinical Significance of Preoperative Hematological Parameters in Patients with D2‐Resected, Node‐Positive Stomach Cancer.
BIOMEDICINES.
10,
7
(2022)
Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma.
CANCERS.
14,
10
(2022)
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial.
Rare Tumors.
-,
-
(2022)
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.
FRONTIERS IN ONCOLOGY.
12,
-
(2022)
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
FUTURE ONCOLOGY.
18,
19
(2022)
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.
INVESTIGATIVE AND CLINICAL UROLOGY.
63,
2
(2022)
Genomic sequencing for bladder urothelial carcinoma and its clinical implications for immunotherapy..
JOURNAL OF CLINICAL ONCOLOGY.
40,
6
(2021)
Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY.
17,
6
(2021)
Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer.
CANCERS.
13,
24
(2021)
A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.
BMC CANCER.
21,
1
(2021)
Detection of aberrant glycosylation of serum haptoglobin for gastric cancer diagnosis using a middle-up-down glycoproteome platform.
JOURNAL OF PERSONALIZED MEDICINE.
11,
6
(2021)
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial.
ANNALS OF ONCOLOGY.
32,
3
(2021)
2020 Korean guidelines for the management of metastatic prostate cancer.
KOREAN JOURNAL OF INTERNAL MEDICINE.
-,
-
(2021)
Impact of radiotherapy on kidney function among patients who received adjuvant treatment for gastric cancer: Logistic and linear regression analyses.
CANCERS.
13,
1
Patent/Intellectual Property
위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
{MARKER FOR PREDICTING STOMACH CANCER PROGNOSIS AND METHOD FOR PREDICTING STOMACH CANCER PROGNOSIS}.
11849123.2.
20180808.
POLAND
위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
{MARKER FOR PREDICTING STOMACH CANCER PROGNOSIS AND METHOD FOR PREDICTING STOMACH CANCER PROGNOSIS}.
11849123.2.
20180808.
GERMANY
위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
{MARKER FOR PREDICTING STOMACH CANCER PROGNOSIS AND METHOD FOR PREDICTING STOMACH CANCER PROGNOSIS}.
11849123.2.
20180808.
SPAIN